In recent decades the advances in care and therapeutic options for people with haemophilia have been extraordinary, transforming the lives of those with severe disease and access to treatment. In contrast,... HTML Version |
PDF Version
|
Print the excerpt
Assessment of health-related quality of life (HRQoL) is relatively new in von Willebrand disease (VWD). So far, generic questionnaires have mainly been used for HRQoL assessment in VWD.
Aims: To assess... HTML Version |
PDF Version
|
Print the excerpt
The gene for von Willebrand factor (VWF) was among the earliest genomic discoveries in the mid-1980s. It became feasible to use this new knowledge to better understand the genetic mechanisms responsible... HTML Version |
PDF Version
|
Print the excerpt
von Willebrand disease (VWD) is a hereditary bleeding disorder first described by Erik von Willebrand in 1926. The disease is characterized by frequent bruising, bleeding from minor wounds, nosebleeds,... HTML Version |
PDF Version
|
Print the excerpt
By requesting access to the "WillebrandXPERT" service, I agree that GNM Healthcare Group Companies USA, Inc. may use the data acquired during my access request to provide me with weekly
information related to its services in accordance with the
Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to
dpo@gnmhealthcare.com.
You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.
